Treatment of pembrolizumab-induced bullous pemphigoid with dupilumab: A case report and review of the literature

By sjmartinez • January 2, 2025

Barghi A, Noveir SD, Mainwaring W, Milani-Nejad N, Bernet L. Treatment of pembrolizumab-induced bullous pemphigoid with dupilumab: A case report and review of the literature. Int J Dermatol. 2024 Dec 30. doi: 10.1111/ijd.17626. Epub ahead of print. PMID: 39739856.

Tags: bullous pemphigoid, Dermatology, DGSOM Student, Dupilumab, eosinophilic annular erythema, immune checkpoint inhibitor, pembrolizumab, Publications

Xenium spatial transcriptomics identifies mesenchymal fibroblast expansion and conserved fibrotic ECM programs in keloid

Deng M, Brewer GM, Espinoza A, Orellana-Montes J, Hedayatyanfard K, Hu C, Jahan MGS, Deriss M, Davis JC, Cheng CE, Pellegrini M, Agak GW. Xenium[...]

Trends in MD-PhD representation and match outcomes across competitive specialties, 2007-2024

Zhou AE, Klufas T, Choi E, Kim YW, Kim JJ, Sarfo A, Sloan B, Feng H. Trends in MD-PhD representation and match outcomes across competitive[...]

Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology

Jonnalagadda A, Lowry WP, Pathak GN, Choi E, Zhou AE, Grant-Kels JM. Ethical Considerations of Cosmetic GLP-1 Receptor Agonist Prescribing in Dermatology. Clin Dermatol. 2026[...]